Leigh Syndrome and Mitochondrial Encephalopathy Gene Panel Test
Cost: AED 7200.0
Test Name: Leigh Syndrome and Mitochondrial Encephalopathy Gene Panel Test
Components: Sterile container/ Sterile Normal Saline Container/EDTA Vacutainer(3 ml)
Price: 7200.0 AED
Sample Condition: Amniotic fluid/ Chorionic villi/ Peripheral blood
Report Delivery: 4-6 weeks
Method: NGS
Test type: Genetics
Doctor: General Physician
Test Department:
Pre Test Information: Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details
The Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel is a genetic test that analyzes a group of genes associated with Leigh syndrome and mitochondrial encephalopathy. These are rare genetic disorders that affect the function of the mitochondria, which are responsible for producing energy in cells.
Leigh syndrome is a progressive neurological disorder that usually appears in infancy or early childhood. It can cause symptoms such as developmental delay, muscle weakness, seizures, and breathing difficulties. Mitochondrial encephalopathy is a broader term that encompasses a range of disorders that affect the brain and nervous system due to mitochondrial dysfunction.
The gene panel test analyzes a set of genes that have been associated with Leigh syndrome and mitochondrial encephalopathy, including MT-ATP6, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-CO1, MT-CO2, MT-CO3, MT-CYB, NDUFA1, NDUFA2, NDUFA4, NDUFA5, NDUFA6, NDUFA8, NDUFA9, NDUFA10, NDUFB3, NDUFB4, NDUFB8, NDUFB9, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, SDHA, SDHB, SDHC, SDHD, SUCLG1, and SURF1.
By analyzing these genes, the test can identify mutations or variations that may be causing or contributing to Leigh syndrome or mitochondrial encephalopathy. This information can help with diagnosis, prognosis, and treatment planning for affected individuals and their families.
Test Name | Leigh Syndrome and Mitochondrial Encephalopathy Gene Panel Test |
---|---|
Components | Sterile container/ Sterile Normal Saline Container/EDTA Vacutainer(3 ml) |
Price | 7200.0 AED |
Sample Condition | Amniotic fluid\/ Chorionic villi\/ Peripheral blood |
Report Delivery | 4-6 weeks |
Method | NGS |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
The Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel is a genetic test that analyzes a group of genes associated with Leigh syndrome and mitochondrial encephalopathy. These are rare genetic disorders that affect the function of the mitochondria, which are responsible for producing energy in cells. Leigh syndrome is a progressive neurological disorder that usually appears in infancy or early childhood. It can cause symptoms such as developmental delay, muscle weakness, seizures, and breathing difficulties. Mitochondrial encephalopathy is a broader term that encompasses a range of disorders that affect the brain and nervous system due to mitochondrial dysfunction. The gene panel test analyzes a set of genes that have been associated with Leigh syndrome and mitochondrial encephalopathy, including MT-ATP6, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MT-CO1, MT-CO2, MT-CO3, MT-CYB, NDUFA1, NDUFA2, NDUFA4, NDUFA5, NDUFA6, NDUFA8, NDUFA9, NDUFA10, NDUFB3, NDUFB4, NDUFB8, NDUFB9, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, SDHA, SDHB, SDHC, SDHD, SUCLG1, and SURF1. By analyzing these genes, the test can identify mutations or variations that may be causing or contributing to Leigh syndrome or mitochondrial encephalopathy. This information can help with diagnosis, prognosis, and treatment planning for affected individuals and their families. |